Last reviewed · How we verify
ESOMEPRAZOLE MAGNESIUM
At a glance
| Generic name | ESOMEPRAZOLE MAGNESIUM |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2001 |
Approved indications
Common side effects
- Headache
- Diarrhea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
Serious adverse events
- GI hemorrhage
- Angioedema
- Anaphylactic reaction
- Larynx edema
- Hepatic function abnormal
- Thrombocytopenia
- Leukopenia
- Melena
Key clinical trials
- Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing (PHASE4)
- Drug Interaction Study on Linaprazan Glurate Capsules (PHASE1)
- Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC (PHASE3)
- A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis (PHASE3)
- Furazolidone Quadruple Regimen Eradicate H. Pylori Infection (PHASE1, PHASE2)
- A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA) (PHASE4)
- Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition (PHASE1)
- Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |